Advances in Research on Neurodegeneration

Chapter 1 Magnetic Resonance: A multimodal approach to the brain?

Chapter 2 Measurement of the dopaminergic degeneration in Parkinson’s disease with [ 123 I]β-CIT and SPECT

Chapter 3 rCBF SPECT in Parkinson’s disease patients with mental dysfunction

Chapter 4 IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism

Chapter 5 Pathophysiology of movement disorders studied using PET

Chapter 6 Contributions of Positron Emission Tomography to elucidating the pathogenesis of Idiopathic Parkinsonism and Dopa Responsive Dystonia

Chapter 7 Mechanism of 6-hydroxydopamine neurotoxicity

Chapter 8 Induction of mitosis-related genes during dopamine-triggered apoptosis in sympathetic neurons

Chapter 9 Neuronal vulnerability in Parkinson's disease.

Chapter 10 N-Methyl-( R )salsolinol as a dopaminergic neurotoxin: From an animal model to an early marker of Parkinson’s disease

Chapter 11 The halogenated tetrahydro-β-carboline “TaClo”: A progressively-acting neurotoxin

Chapter 12 Developmental and genetic regulation of programmed neuronal death

Chapter 13 Apoptosis in neurodegenerative disorders

Chapter 14 Mechanisms of cell death in Alzheimer’s disease

Chapter 15 Assessment of neurotoxicity and “neuroprotection”

Chapter 16 Update on management and genetics of multiple sclerosis.

Chapter 17 Pathogenesis of immune-mediated demyelination in the CNS

Chapter 18 Basic mechanisms of brain inflammation

Chapter 19 Cell death in prion disease